GCA
CEMI

Greenwood Capital Associates’s Chembio diagnostics, Inc. CEMI Stock Holding History

Greenwood Capital Associates’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-19,325
Closed -$94K – 215
2020
Q3 		$94K Sell
19,325
-38,327
-66% -$182K 0.02% 182
2020
Q2 		$187K Buy
+57,652
New +$547K 0.04% 179

Other funds holding CEMI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
FA
Friess Associates Greenville, Delaware $59.9M AUM 3.42% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
USPCM
Union Square Park Capital Management New York $176M AUM 51.52% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Greenwood Capital Associates's CEMI Position: Q4 2020 in Review

Greenwood Capital Associates sold out of Chembio diagnostics, Inc. (CEMI) in Q4 2020, closing a stake of 19,325 shares — an estimated $94K sold.

Greenwood Capital Associates first reported a position in CEMI in Q2 2020 and held it in 2 quarters. The position peaked at $187K in Q2 2020. 77 funds tracked by Wall St. Rank hold CEMI as of Q4 2020.

  • Greenwood Capital Associates reported no remaining Chembio diagnostics, Inc. position as of Q4 2020 after selling out during the quarter.
  • Greenwood Capital Associates sold 19,325 Chembio diagnostics, Inc. shares in Q4 2020, an estimated $94K.
  • Greenwood Capital Associates first reported a position in Chembio diagnostics, Inc. in Q2 2020 and held it in 2 quarters.
  • Greenwood Capital Associates's Chembio diagnostics, Inc. position peaked at $187K in Q2 2020.
  • 77 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q4 2020.

Based on Greenwood Capital Associates's 13F filing for Q4 2020, filed 9 Feb 2021.